Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

49°
- Poteau, OK (74953)
  Today
  
  Cloudy early with peeks of sunshine expected late. Expect mist and reduced visibilities at times. High 67F. Winds light and variable..
  
  Tonight
  
  Rain likely. Low 52F. Winds light and variable. Chance of rain 100%. Rainfall around a quarter of an inch.
  
  Updated: November 23, 2025 @ 3:14 am
- Full Forecast

Site search

Home
News
Sports
Obituaries
Photos
PDN E-Edition
Classifieds
- Place an ad
Antlers American E-Edition
Archives
Best of 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Novartis AG Common Stock (NY:NVS)

127.31 +2.95 (+2.37%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

52 53 Next >

Avenue Z Hires Leading Digital Media and Technology Executive David Corchado to Lead Team in Global Strategy

October 24, 2023

--News Direct--

Via News Direct

US Stock Futures Surge Ahead Of Microsoft, Google Earnings: Analyst Says 'Magnificent Seven' Unlikely To See Tesla-Like Volatility After Results ↗

October 24, 2023

Buoyed by earnings optimism, stocks appear on track for a positive open on Tuesday after the tech-heavy Nasdaq Composite Index snapped a four-day losing streak in the previous session. The uptick in...

Via Benzinga

Topics Bonds Stocks

Novartis Q3: Earnings Beat, Raised Operating Profit Outlook & More ↗

October 24, 2023

Novartis AG (NYSE: NVS) reported

Via Benzinga

Topics Earnings

Earnings Outlook For Novartis ↗

October 23, 2023

Via Benzinga

Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? ↗

October 23, 2023

Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises.

Via Benzinga

Topics Stocks

7 Healthcare Stocks to invest in for a Healthy Future ↗

October 20, 2023

Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners.

Via InvestorPlace

2 Biotech Stocks That Could Make You Richer ↗

October 17, 2023

These two well-known drugmakers still have some growth fuel in their seemingly empty tanks.

Via The Motley Fool

3 Unstoppable Stocks to Buy and Hold for Decades ↗

October 17, 2023

These stocks can be pillars for your long-term portfolio, and investing in all three offers excellent diversification.

Via The Motley Fool

Why Top 1% Biotech MoonLake Just Surged Within Striking Distance Of A Breakout ↗

October 16, 2023

MoonLake says it's skin-disease treatment showed improved promise in a 24-week testing update.

Via Investor's Business Daily

Weight Loss Drugs Market Size, Share, Growth, Trends, Analysis 2028

October 13, 2023

Get an extensive Weight Loss Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.

Via SBWire

Antiparasitic Drugs Market to See Major Growth by 2023-2030 : Arbor Pharmaceuticals, GlaxoSmithKline, Cipla

October 11, 2023

Get an extensive Antiparasitic Drugs Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.

Via SBWire

RayzeBio Is A New Contender in Radiopharmaceutical Arena, Will Attract Prominent Entities: JP Morgan ↗

October 10, 2023

JP Morgan has initiated coverage on RayzeBio Inc (NASDAQ: RYZB), representing a pure-play opportunity in the radiopharmaceutical space.

Via Benzinga

Cancer Immunotherapies Market Set for More Growth : American Cancer Society, WebMD, Eli Lily and Company

October 10, 2023

Get an extensive Cancer Immunotherapies Market analysis of the dominant vendors, their latest products and services, and the competitive landscape of the industry.

Via SBWire

AbbVie Stock Moves Higher With Rising Relative Strength ↗

October 10, 2023

A Relative Strength Rating upgrade for AbbVie shows improving technical performance. Will it continue?

Via Investor's Business Daily

Elsevier Launches New Pharmapendium, Empowering Pharma Companies to Bring Novel Drugs to Market Faster and Increase Success of Regulatory Submissions

October 10, 2023

London, United Kingdom--(Newsfile Corp. - October 10, 2023) - Elsevier, a global leader in information and data analytics, has launched...

Via Newsfile

Topics Animal Testing

3 Artificial Intelligence Stocks That Could Outperform the ‘Godfather of AI’ ↗

October 09, 2023

These are the AI stocks to buy and hold for multibagger returns in the next 24 months, as they represent quality growth companies.

Via InvestorPlace

Topics Artificial Intelligence

Eli Lilly, McKesson, Novartis Flash Promising Chart Action

October 09, 2023

Eli Lilly, McKesson, and Novartis are catching investors' attention with promising chart patterns and revenue growth, signaling potential buying opportunities.

Via MarketBeat

Protecting Cannabis Products & More: New Sustainable Child-Resistant Packaging By Dymapak ↗

October 05, 2023

Dymapak, a global manufacturer specializing in innovative child-resistant packaging solutions for various industries, has introduced a child-resistant Consumer Packaged Goods (CPG) packaging...

Via Benzinga

Topics Cannabis

Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 04, 2023

Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2...

Via Benzinga

Novartis Shares Decline As Spin Off Sandoz's Market Debut Falls Short of Expected Valuation ↗

October 04, 2023

Sandoz Group AG (OTC: SDZNY) (OTC: SDZXF) enters a new era as a standalone player in generic and biosimilar medicines.

Via Benzinga

SDZNY Stock: 7 Things to Know as Novartis Spinoff Sandoz Starts Trading Today ↗

October 04, 2023

Sandoz (SDZNY) stock is a hot topic among traders on Wednesday as the company starts trading after a spinoff from Novartis.

Via InvestorPlace

Cancer Drug Maker 3D Medicines Inc. Trading Higher After Company Announces It Will Repurchase Up To 10% Of Outstanding Shares ↗

October 04, 2023

3D Medicines Inc. was trading 7.2% higher in the Hong Kong Wednesday morning session at HK$5.53 after the company announced that it is buying back up to 10% of its own stock.

Via Benzinga

Cal-Maine Foods, A10 Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 04, 2023

U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift ↗

October 03, 2023

Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy...

Via Benzinga

Drugmakers Agree To Participate For Medicare Drug Price Negotiation With Biden Administration ↗

October 03, 2023

All ten manufacturers of the first drugs selected for Medicare price negotiations will be participating, the White House said, even though many of them are suing the administration

Via Benzinga

Novartis' Investigational Therapy Shows Promising Action In Rare Kidney Disease ↗

October 02, 2023

Novartis AG (NYSE: NVS) announced topline results from the pre-specified interim analysis of the Phase 3 APPLAUSE-IgAN study at nine months of iptacopan, an investigational factor B inhibitor targeting...

Via Benzinga

Cardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)

October 02, 2023

Via AB Newswire

Topics Death

Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer ↗

September 29, 2023

Oppenheimer initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN), citing the company's pipeline as among the best in the space with alpha-emitter-based targeted radionuclide therapies...

Via Benzinga

Allakos' Antibodies For Chronic Skin Conditions, Analyst Sees Over 400% Stock Upside ↗

September 27, 2023

JMP Securities initiated coverage on Allakos Inc (NASDAQ: ALLK), noting novel monoclonal antibodies targeting Siglec (sialic acid immunoglobulin-like lectin) receptors on immune cells that are drivers...

Via Benzinga

Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges ↗

September 27, 2023

Ionis Pharmaceuticals Inc (NASDAQ: IONS) entered an agreement with Roche Holdings AG (OTC: RHHBY

Via Benzinga

< Previous 1 2

...

16 17 18 19 20 21 22 23 24

...

52 53 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Poteau Daily News

PoteauDailyNews.com
804 N. Broadway
Poteau, OK 74953
Phone: 918-647-3188
Email: circulation@poteaudailynews.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Poteau, OK (74953)

Today

Tonight

Novartis AG Common Stock (NY:NVS)

All News about Novartis AG Common Stock

Sections

Services

Poteau Daily News